InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,943.81
(
0.08%
)
Post# of 123782
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

KWills

Send PM Follow Ignore
Followers 0
Posts 4
Boards Moderated 0
Alias Born 06/13/2017

KWills

Re: None

Tuesday, 08/15/2017 9:41:53 AM

Tuesday, August 15, 2017 9:41:53 AM

Post# of 123782
CEO, Linda Powers to speak on "Novel Personalize Immune Therapies for Solid Tumors"

Linda Powers will discuss Northwest Bio’s DCVax® platform technology, a personalized, dendritic cell based active immunotherapy for solid tumors at this year's 6th annual Cancer Vaccines conference.
Unlike conventional cancer drugs and other immune therapies, which use one active agent to hit one target on the cancer, DCVax mobilizes many active agents of the immune system to hit many targets on the cancer. For more information, please visit www.cancervaccinesevent.com/ihub
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up